雌激素受体阳性(estrogen receptor-positive,ER-positive)乳腺癌的内分泌治疗始于上世纪70年代,选用的药物有选择性雌激素受体调节剂(selective est...
基于4个网页-相关网页
These trends were most notable in women with estrogen receptor-positive cancers, the researchers note.
上述趋势在雌激素受体阳性乳腺癌患者表现最明显。研究者写道。
According to this new study, yes, it is beneficial to both women who have estrogen receptor positive tumors and estrogen receptor negative tumors.
根据这项新的研究，的确，对雌激素受体阳性肿瘤和雌激素受体阴性肿瘤的妇女都有利。
It would also be important for treatment and prognosis to determine if these cells were estrogen and progesterone receptor positive.
确定这些细胞雌激素与孕激素受体阳性与否对治疗与预后也很重要。
应用推荐